Drug Delivery Platforms
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
49
NCT03854721
A Phase 1 Study of Intravesical VAX014 for Instillation in Subjects With Non-Muscle Invasive Bladder Cancer
Phase: Phase 1
Role: Lead Sponsor
Start: May 10, 2019
Completion: Mar 1, 2023
NCT05901285
Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors
Start: Nov 2, 2023
Completion: Nov 30, 2026
Loading map...